Nucleic Acid Conf 2020
Track 1: Molecular Medicine
Molecular medicine is a broad field which deals with the development of diseases at a molecular level and identifies fundamental molecular and genetic errors of disease and to develop molecular interventions to correct them. Molecular structures and mechanisms are described by Physical, chemical, biological, bioinformatics and medical techniques. Disease pathogenesis at the molecular or physiological level may lead to the design of specific tools for disease diagnosis, treatment, or prevention. By understanding the genes, proteins, and other cellular molecules work molecular medicine develops ways to diagnose and treat disease. Molecular Medicine develops knowledge and skills in cellular and molecular biology.
- Molecular Medicine Cancer
- Molecular Medicine Scope
- Molecular Mechanisms
- Molecular Surgery
- Molecular pathological epidemiology
Track 2: Molecular Diagnostics
Molecular diagnostics is a collection of techniques used to analyse an individual's genetic code and to identify biological markers in the genome and proteome. Molecular diagnostics apply molecular biology to see how cell express their genes to medical testing. For any successful application of gene therapy or biologic response modifiers, molecular diagnostics offers a great tool. Molecular diagnostics now provides most laboratory tests in infectious diseases, genetics, and an increasing number in oncology. Molecular diagnostics analyse a person's health at a molecular level by detecting specific sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) that may be related to disease
- Genetic Tests
- Molecular Tests
- Polymerase Chain Reaction
- Molecular Diagnostics Market
- Molecular Biology
- Medical Testing
- Genetic hybridization tests
Track 3: Molecular Genetics and Genomics
Molecular genetics employs methods of both molecular biology and genetics to study the structure, function and interactions among genes at a molecular level. The study of chromosomes and gene expression of an organism can give an accurate and deep understanding of heredity, genetic variation, and mutations. Molecular Genetics and Genomics cover all areas on the latest research innovations, population genetics, gene function and expression and molecular genetics. Molecular genetics is concerned with the study of your favourite gene, genomics is concerned with studying all the genes. Molecular genomics is a critical component of the expanding database linking alterations of DNA and RNA with the disease, disease prognosis and therapeutic response.
- Genes and genomes
- PCR and Real-Time PCR
- Next-Generation Sequencing
- Sanger Sequencing
Track 4: Molecular Oncology
Molecular oncology refers to the chemistry of cancer and tumours at the molecular scale and their development and application on molecularly targeted therapies. Molecular Oncology studies especially the genetic alterations and their implications. Molecular Oncology focuses on new discoveries, approaches, as well as technical developments in basic, clinical and discovery-driven cancer research. It mainly focuses on advances in the understanding of disease processes leading to human tumour development. Molecular Oncology establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies.
- DNA repair
- Cancer genetics
- Molecular pathology
- Tumour immunology
Track 5: Molecular Biomarkers and Diagnosis
A biomarker is used as an indicator of the biological state. In routine clinical use Oncology biomarkers actually, make their way. A biological marker points to the presence of a disease, a physiological change, response to treatment, or a psychological condition. Molecular biomarkers are used for various purposes including disease diagnosis and prognosis and assessment of treatment response. Over the last decade, there has been a significant increase in the number of drug labels containing information on molecular biomarkers. In most of the chronic diseases, biomarkers can confirm a difficult diagnosis or even make it possible in the first place.
- Genetic Testing and Molecular Biomarkers
- Drug labelling
- Cancer biomarkers
- Disease-related biomarkers
- Drug-related biomarkers
- Biomarkers in Drug Development
- Biomarker requirements
Track 6: Cellular and Molecular Biology
Molecular biology is the study of biological activity between biomolecules in the various systems of a cell. It also includes the interactions between DNA, RNA, proteins and their biosynthesis as well as the regulation of these interactions. Cellular and Molecular Biology majorly study the processes that occur within and between the body's cells. This includes genes, the way cells carry nutrients throughout the body, and how diseases attack healthy cells. The process of replication, transcription and translation of the genetic material are studied under Molecular biology. Cellular biology study cells, including their function, systems, structure and interactions with living organisms. These typically work in medical fields and are often focused on the treatment of disease.
- Cell signalling
- Structural biology
Track 7: Molecular Pathology
Molecular pathology is the study of molecules within organs, tissues or bodily fluids. Molecular pathology is commonly used in the diagnosis of bone, soft tissue tumours, cancer and infectious diseases. The purpose of molecular pathology is to understand the mechanisms of disease by identifying molecular and pathway alterations. It is considered the heart of modern diagnostics and translational research. Molecular pathology studies and diagnose disease through the examination of genetic and molecular abnormalities. Molecular pathology and biomarkers are used to study molecular and genomic abnormalities in tissues for diagnostic and prognostic purposes. Molecular diagnosis is useful and sometimes necessary as an adjunct for diagnosis especially in morphologically or clinically unusual lesions.
- Molecular diagnostics
- Molecular Genetic Pathology
- Medical Genetics
- Molecular tests
- Molecular pathological epidemiology
- Precision medicine
Track 8: Molecular Evolution
Living things all are alike at the cellular and molecular level. The fundamental similarities between living organisms are explained by evolutionary theory. Major topics in molecular evolution concern the rates and impacts of single nucleotide changes, origins of new genes, the evolution of development, and ways that evolutionary forces influence genomic and phenotypic changes. Some of the key advances are quantitative estimates of both the diversity in populations and of evolutionary relationships, as well as improvements in theoretical understanding. There is an improved understanding of the function of proteins and much better models of the common patterns of development.
- Mechanisms of molecular evolution
- Evolutionary biology
- Population genetics
- Genetic drift
- Gene content and distribution
- Molecular phylogenetics
Track 9: Advances in Molecular Diagnostics
Advances in cell and molecular biology studies have revolutionized the diagnosis and treatment of many different diseases. It is considered as a modern Biotechnology concerned with understanding the Genetic Diagnosis, Molecular Diagnosis, Molecular Forensics. People at the present day are facing serious global challenges in healthcare from emerging and re-emerging diseases. The availability of new sequencing methods, microarrays, microfluidics, biosensors, and biomarker assays has made a shift toward developing diagnostic platforms, which stimulates growth in the field regarding diagnosis, prognosis, and treatment, leading to improved outcomes and greater cost savings.
- Genetic Marker
- Cancer Biomarkers
- Biomarker Toxicologies
- Inherited Diseases
Track 10: Prenatal Molecular Diagnostics
Much research is being done in foetal whole exome sequencing and is beginning to play a large role in miscarriage testing. With all this research and screening, clinicians and genetic counsellors need to keep abreast of these changes and guidelines in order to effectively care for patients. The genetic cause of foetal abnormalities detected on ultrasound imaging and in high-risk families can be significantly identified and improved in Foetal diagnostic exome sequencing. Testing based on isolation of foetal cells from maternal blood would provide an attractive alternative to testing of cell-free DNA. An updated implementation of these different approaches will make lively discussion and insight into this field and is headed ways for researchers, test providers, clinicians and clinics to take these developments into consideration.
- Advances in Prenatal Molecular Diagnostics
- Cell-free DNA screening
- Cell-based DNA testing
- Biomarkers for preeclampsia and pre-term birth
- Prenatal and Reproductive Diagnostics
- Non-Invasive Prenatal Diagnosis
Track 11: Point-of-Care Diagnostics
Point-of-care testing is medical diagnostic testing at the time and place of patient care. In Recent years there are tremendous advances in POCD due to innovations lab-on-a-chip technologies, and complementary technologies. Critical advances in POCD provides directions for future research. Point-of-care allows physicians and medical staff to accurately achieve real-time, lab-quality diagnostic results within minutes rather than hours. The global Point of Care diagnostic tests renders immediate results providing improved patient care in rural areas too. This factor has significantly impacted the market growth.
- Point-of-Care Testing by Clinical Setting
- Point-of-Care Testing Patents
- Chronic Disease Management at the Point of Care
- POC Informatics
- Increasing Global Access to Care
- Portable Point-Of-Care Testing Systems
Track 12: Clinical Diagnostics & Research
Clinical diagnostics is defined as diagnosis and treatment of human disease. Clinical diagnostics for a disease can be done by patient's complaints based on signs, symptoms and medical history rather than on laboratory examination or medical imaging. Clinical diagnostics is considered as an ever-changing field of medicine and research. In recent years Clinical diagnostics has become more exciting as advances in new techniques aid in fulfilling the potential of personalized medicine. Clinical research determines the safety and effectiveness of medications, devices, diagnostic products and treatments.
- Differential diagnosis
- Diagnostic Test
- Nursing diagnosis
- Clinical diagnosis of ADHD
- Clinical research ethics
- Clinical Trial Management System
- Clinical Biostatistics
Track 13: Biosimilar Monoclonal Antibodies
A monoclonal antibody (mAb) is originally produced by a single B-cell. Biosimilars are a lot complicated than small-molecule medicine and generics. In the past few years, monoclonal antibody drugs have dominated the world's largest biopharmaceutical drug sales, and in the coming years, monoclonal antibody drugs will continue to be the main force. Considering the huge profit margins and potential market, the monoclonal antibody-based therapeutics is the hot territory many pharmaceutical companies chases. This session will summarize the market in terms of therapeutic applications, type, and structure of mAbs, dominant companies, manufacturing locations, and emerging markets. These requirements would lead to greater development in the process and tighter quality controls during the production of biosimilar mAbs.
- FDA-approved mAb drugs
- Monoclonal antibody therapy
- Anti-Cancer Antibodies
- Cancer Immune therapy
- Antibody Humanization Technologies
- Biotherapeutics : Early Analytical Development
Track 14: Infectious Diseases
Infectious diseases are caused by pathogenic organisms such as viruses, bacteria, or fungus. Normally harmless but under certain conditions, they can be fatal and can cause death too. They can be spread from one person to another directly or indirectly. Infectious diseases are caused by infection-causing organisms that use the human body for surviving, reproducing and colonizing. These organisms are known as pathogens. Antibiotics are used to treat bacterial infections; Antiviral agents treat viral infections; and Antifungal agents treat fungal infections.
- Urinary Tract Infections
- Neurodegenerative Diseases
- Cryptococcal meningitis
- Bacterial Infectious Diseases
- Viral Infectious Diseases
- Protozoal Infectious Diseases
- Fungal Infectious Diseases
- Zoonotic diseases
Track 15: Next-Generation Sequencing
Next-generation sequencing (NGS) has revolutionised the study of genomics and molecular biology by allowing us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing. Next Generation Sequencing (NGS) relies on capillary electrophoresis. NGS although with shorter read lengths and less accuracy reduces the time that genome sequencing projects took with Sanger methods. Thousands to millions of DNA molecules can be sequenced simultaneously by using Powerful Next Generation Sequencing (NGS) platform. By offering a high throughput option NGS is revolutionizing in fields such as personalized medicine, genetic diseases, and clinical diagnostics.
- llumina (Solexa) sequencing
- Roche 454 sequencing
- Proton / PGM sequencing
- SOLiD sequencing
- Massive parallel sequencing
- Sanger sequencing
To share your views and research, please click here to register for the Conference.